Sara Bonstein

Insider Reports History

Entity
Individual
Location
305 College Road East, Princeton, NJ
Signature
/s/ Julia Walcott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sara Bonstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INSMED Inc Chief Financial Officer Common Stock 117K $5.87M $50.00 May 29, 2024 Direct
INSMED Inc Chief Financial Officer Stock Option (right to buy) 59.4K $1.22M $20.49 May 29, 2024 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 14, 2024 Direct
scPharmaceuticals Inc. Director Stock Option (Right to Buy) 19.8K Jun 11, 2024 Direct

Insider Reports Filed by Sara Bonstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
SCPH scPharmaceuticals Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
INSM INSMED Inc May 28, 2024 26 -$5.66M 4 May 30, 2024 Chief Financial Officer
INSM INSMED Inc May 13, 2024 3 -$281K 4 May 15, 2024 Chief Financial Officer
INSM INSMED Inc Jan 9, 2024 1 -$131K 4 Jan 11, 2024 Chief Financial Officer
INSM INSMED Inc Jan 4, 2024 2 $0 4 Jan 5, 2024 Chief Financial Officer
INSM INSMED Inc Dec 22, 2023 1 -$396K 4 Dec 22, 2023 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
SCPH scPharmaceuticals Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
INSM INSMED Inc May 15, 2023 2 -$72.4K 4 May 17, 2023 Chief Financial Officer
INSM INSMED Inc May 11, 2023 3 $0 4 May 15, 2023 Chief Financial Officer
INSM INSMED Inc Jan 10, 2023 1 -$51.8K 4 Jan 12, 2023 Chief Financial Officer
INSM INSMED Inc Jan 5, 2023 3 $0 4 Jan 6, 2023 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
SCPH scPharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
INSM INSMED Inc May 16, 2022 1 -$26.5K 4 May 18, 2022 Chief Financial Officer
INSM INSMED Inc May 11, 2022 2 $0 4 May 13, 2022 Chief Financial Officer
INSM INSMED Inc Jan 11, 2022 1 -$29K 4 Jan 13, 2022 Chief Financial Officer
INSM INSMED Inc Jan 6, 2022 2 $0 4 Jan 10, 2022 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director
SCPH scPharmaceuticals Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
INSM INSMED Inc May 12, 2021 2 $0 4 May 14, 2021 Chief Financial Officer